Embla Medical hf. (CPH:EMBLA)

Market Cap	14.24B
Revenue (ttm)	5.92B
Net Income (ttm)	498.15M
Shares Out	426.22M
EPS (ttm)	1.17
PE Ratio	28.60
Forward PE	25.78
Dividend	n/a
Ex-Dividend Date	n/a

Volume	32,257
Average Volume	64,428
Open	35.30
Previous Close	33.60
Day's Range	33.40 - 35.30
52-Week Range	25.01 - 38.00
Beta	0.58
RSI	56.42
Earnings Date	Jul 22, 2025

About Embla Medical

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints. Its Bracing and Supports segment provides bracing and...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1971
• Employees: 4,061
• Stock Exchange: Copenhagen Stock Exchange
• Ticker Symbol: EMBLA

Financial Performance

In 2024, Embla Medical's revenue was $854.89 million, an increase of 8.81% compared to the previous year's $785.68 million. Earnings were $68.28 million, an increase of 16.94%.

Financial numbers in USD